124 related articles for article (PubMed ID: 3121560)
1. Heterogeneous distribution of acidic TA-4 in cervical squamous cell carcinoma: immunohistochemical demonstration with monoclonal antibodies.
Kato H; Suehiro Y; Morioka H; Torigoe T; Myoga A; Sekiguchi K; Ikeda I
Jpn J Cancer Res; 1987 Nov; 78(11):1246-50. PubMed ID: 3121560
[TBL] [Abstract][Full Text] [Related]
2. [Tumor antigen TA-4 of squamous cell carcinoma in patients with cervical cancer].
Kato H; Morioka H; Aramaki S; Tamai K; Nagaya T; Nagai M; Torigoe T
Gan No Rinsho; 1984 May; 30(6 Suppl):574-7. PubMed ID: 6748228
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of a tumor antigen TA-4 of squamous cell carcinoma in relation to its appearance in the circulation.
Kato H; Nagaya T; Torigoe T
Gan; 1984 May; 75(5):433-5. PubMed ID: 6745563
[TBL] [Abstract][Full Text] [Related]
4. [Clinical significance of tumor associated antigen TA-4 in gynecologic tumors].
Inoue Y; Ueda G; Yamasaki M; Inoue M; Tanaka Y; Hiramatsu K; Nishino T; Saito J; Abe Y
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jun; 37(6):919-22. PubMed ID: 3894536
[TBL] [Abstract][Full Text] [Related]
5. Blood group antigen expression and prognosis in squamous cell carcinoma of the uterine cervix.
Lindgren A; Stendahl U; Brodin T; Lundblad A; Sällström J; Busch C
Anticancer Res; 1986; 6(2):255-8. PubMed ID: 2423015
[TBL] [Abstract][Full Text] [Related]
6. [Immunomorphological studies of the antigen associated with squamous cell cancer of the human cervix uteri].
Ievleva ES; Marshutina NV; Ageenko AN; Khmel'nitskaia NG
Biull Eksp Biol Med; 1992 Mar; 113(3):304-6. PubMed ID: 1421235
[TBL] [Abstract][Full Text] [Related]
7. The use of a tumor antigen TA-4 for the management of squamous cell carcinoma.
Kato H; Tamai K; Nagaya T; Nagai M; Torigoe T
Cancer Detect Prev; 1985; 8(1-2):155-9. PubMed ID: 4064035
[TBL] [Abstract][Full Text] [Related]
8. Tumor-associated antigen 22-1-1 expression in the uterine cervical squamous neoplasias.
Sonoda K; Kaku T; Kamura T; Nakashima M; Watanabe T; Nakano H
Clin Cancer Res; 1998 Jun; 4(6):1517-20. PubMed ID: 9626471
[TBL] [Abstract][Full Text] [Related]
9. [Immunohistochemical study of condyloma and and carcinoembryonic antigens in the uterine cervix in human papilloma virus infection and neoplasia].
Alcántara-Vázquez A; Rodríguez-Martínez HA; Gómez-Ramírez AM; Cruz-Ortiz H; Orozco-Estéves H
Rev Invest Clin; 1985; 37(4):291-6. PubMed ID: 3006200
[No Abstract] [Full Text] [Related]
10. Discordant induction of tumor-associated antigen, TA-4 and chorionic gonadotropin beta in cultured cervical carcinoma cells.
Maruo T; Matsuo H; Nishino R; Hussa RO; Strobel JL; Pattillo RA; Mochizuki M
Nihon Sanka Fujinka Gakkai Zasshi; 1987 Feb; 39(2):291-6. PubMed ID: 3493311
[TBL] [Abstract][Full Text] [Related]
11. Tumor-associated antigen, TA-4, in the monitoring of the effects of therapy for squamous cell carcinoma of the uterine cervix. Serial determinations and tissue localization.
Maruo T; Shibata K; Kimura A; Hoshina M; Mochizuki M
Cancer; 1985 Jul; 56(2):302-8. PubMed ID: 2408732
[TBL] [Abstract][Full Text] [Related]
12. [Prediction of the recurrence of squamous cell carcinoma of the uterine cervix by monitoring serum TA-4].
Oishi T; Maruo T; Yamasaki M; Mochizuki M
Nihon Sanka Fujinka Gakkai Zasshi; 1987 May; 39(5):799-806. PubMed ID: 3598275
[TBL] [Abstract][Full Text] [Related]
13. [Production and characterization of monoclonal antibody to uterine cervical cancer cell line SKG-IIIa].
Nozawa S; Narisawa S; Takayama Y; Kurihara S; Mukai M
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Dec; 37(12):2767-74. PubMed ID: 2418136
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies to human squamous cell carcinoma of the lung and their application to tumor diagnosis.
Kyoizumi S; Akiyama M; Kouno N; Kobuke K; Hakoda M; Jones SL; Yamakido M
Cancer Res; 1985 Jul; 45(7):3274-81. PubMed ID: 4005855
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometric analysis of tumor antigen TA-4 in cervical squamous cells.
Sasaki K; Nagai M; Kato H; Torigoe T; Nagamine Y; Takahashi M
Gan; 1984 Aug; 75(8):703-6. PubMed ID: 6386588
[TBL] [Abstract][Full Text] [Related]
16. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix.
Juang CM; Wang PH; Yen MS; Lai CR; Ng HT; Yuan CC
Gynecol Oncol; 2000 Jan; 76(1):103-6. PubMed ID: 10620449
[TBL] [Abstract][Full Text] [Related]
17. [Immunohistochemical tissue localization of TA-4 and CEA in uterine carcinomas].
Kimura A; Maruo T; Hoshina M; Mochizuki M
Nihon Gan Chiryo Gakkai Shi; 1987 Jul; 22(6):1159-68. PubMed ID: 3323375
[No Abstract] [Full Text] [Related]
18. [Effects of cytokine on expression of tumor antigen TA-4 in squamous cell carcinoma].
Kobayashi M
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Apr; 41(4):412-8. PubMed ID: 2746067
[TBL] [Abstract][Full Text] [Related]
19. Patterns of CEA-related antigen expression in invasive squamous carcinoma of the cervix.
Sanders DS; Ferryman SR; Bryant FJ; Rollason TP
J Pathol; 1993 Sep; 171(1):21-6. PubMed ID: 7901354
[TBL] [Abstract][Full Text] [Related]
20. Immunoreactivity of recombinant squamous cell carcinoma antigen and leupin/SCCA-2: implications for tumor marker detection.
Barnes RC; Coulter J; Worrall DM
Gynecol Oncol; 2000 Jul; 78(1):62-6. PubMed ID: 10873412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
